Aimei Health Technology Co Right
AFJKR
14 hedge funds and large institutions have $1.16M invested in Aimei Health Technology Co Right in 2024 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 3 increasing their positions, 2 reducing their positions, and 1 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 2
15% more capital invested
Capital invested by funds: $1.01M → $1.16M (+$149K)
7% less funds holding
Funds holding: 15 → 14 (-1)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| 1 |
CAC
Cowen and Company
New York
|
+$96.8K |
| 2 |
SCM
Shaolin Capital Management
Miami,
Florida
|
+$13.1K |
| 3 |
RCM
Rivernorth Capital Management
West Palm Beach,
Florida
|
+$3.54K |
Top Sellers
| 1 |
EAM
Exos Asset Management
New York
|
-$33.7K |
| 2 |
GCL
Glazer Capital LLC
New York
|
-$6.15K |
| 3 |
CS
Clear Street
New York
|
-$2.48K |
AFJKR Hedge Fund Activity: Q3 2024 in Review
14 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Aimei Health Technology Co Right (AFJKR) for Q3 2024, worth a combined $1.16M — up 15% from $1.01M a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of AFJKR and 0 opened new positions — a net loss of 1 holder — while 2 trimmed existing stakes and 3 added.
The largest buyer was Cowen and Company, adding an estimated $96.8K. The largest seller was Exos Asset Management, exiting entirely with an estimated $33.7K sold.
- 14 institutional investors held Aimei Health Technology Co Right (AFJKR) as of Q3 2024, down from 15 in Q2 2024.
- Funds reported $1.16M of Aimei Health Technology Co Right stock for Q3 2024, up 15% quarter-over-quarter.
- 0 funds opened new Aimei Health Technology Co Right positions in Q3 2024 and 1 closed out, a net change of -1 holder.
- The largest Aimei Health Technology Co Right buyer in Q3 2024 was Cowen and Company, an estimated $96.8K added.
- The largest Aimei Health Technology Co Right seller in Q3 2024 was Exos Asset Management, an estimated $33.7K sold.
Based on aggregated 13F filings for Q3 2024.